Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Capital Expenditures (2018 - 2024)

Dna X (SONM) has disclosed Capital Expenditures for 7 consecutive years, with $8000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Capital Expenditures fell 33.33% year-over-year to $8000.0, compared with a TTM value of $214000.0 through Dec 2024, up 1326.67%, and an annual FY2024 reading of $214000.0, up 494.44% over the prior year.
  • Capital Expenditures was $8000.0 for Q4 2024 at Dna X, down from $137000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $184000.0 in Q1 2020 and bottomed at -$74000.0 in Q2 2020.
  • Average Capital Expenditures over 5 years is $27785.7, with a median of $10000.0 recorded in 2023.
  • The sharpest move saw Capital Expenditures crashed 2366.67% in 2020, then skyrocketed 13600.0% in 2024.
  • Year by year, Capital Expenditures stood at $20000.0 in 2020, then grew by 30.0% to $26000.0 in 2021, then crashed by 92.31% to $2000.0 in 2022, then surged by 500.0% to $12000.0 in 2023, then tumbled by 33.33% to $8000.0 in 2024.
  • Business Quant data shows Capital Expenditures for SONM at $8000.0 in Q4 2024, $137000.0 in Q3 2024, and $39000.0 in Q2 2024.